In an exclusive interview with the Record, Dr Arianna Andreangeli tells how the NHS has further deteriorated since Brexit. / Scotland is facing a crisis in its National Health Service due to Covid and Tory austerity - but Brexit has caused further deadly delays in our hospitals.

Leading pharmaceutical research firm finds some drug firms will withdraw up to 90 per cent of their products from Northern Ireland as protocol hits exports.

Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions.

The UK’s MHRA may have to lay off about 300 of its 1,200 employees, thanks to a decline in income due to reduced medical product submissions following Brexit, spurring anger among unions across the island.

And it will cost more here because of the UK pulling out of the European Medicines Agency on 30 December.

Ministers will relax rules around clinical trials and streamline the approval of new medicines in a bid to maintain Britain’s competitiveness following Brexit.

David Meek, the CEO of Ipsen, warns Britain leaving the European Union has seen the country fall down the list of priorities.